ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 104 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $393,000 | -60.3% | 249,021 | 0.0% | 0.02% | -76.8% |
Q3 2019 | $989,000 | -45.1% | 249,021 | 0.0% | 0.08% | -34.9% |
Q2 2019 | $1,803,000 | +9.5% | 249,021 | 0.0% | 0.13% | +48.2% |
Q1 2019 | $1,646,000 | -7.7% | 249,021 | -90.0% | 0.08% | +19.7% |
Q4 2018 | $1,783,000 | -62.5% | 2,490,204 | 0.0% | 0.07% | -65.4% |
Q3 2018 | $4,756,000 | -66.3% | 2,490,204 | 0.0% | 0.20% | -68.9% |
Q2 2018 | $14,095,000 | +33.8% | 2,490,204 | 0.0% | 0.66% | +40.7% |
Q1 2018 | $10,534,000 | -20.9% | 2,490,204 | 0.0% | 0.47% | -15.0% |
Q4 2017 | $13,323,000 | +20.0% | 2,490,204 | 0.0% | 0.55% | +41.9% |
Q3 2017 | $11,106,000 | -8.2% | 2,490,204 | 0.0% | 0.39% | -11.6% |
Q2 2017 | $12,102,000 | -32.9% | 2,490,204 | 0.0% | 0.44% | -29.8% |
Q1 2017 | $18,029,000 | +26.6% | 2,490,204 | 0.0% | 0.63% | +10.8% |
Q4 2016 | $14,244,000 | -55.3% | 2,490,204 | 0.0% | 0.57% | -60.4% |
Q3 2016 | $31,875,000 | +2.7% | 2,490,204 | 0.0% | 1.43% | -11.1% |
Q2 2016 | $31,028,000 | +49.0% | 2,490,204 | 0.0% | 1.61% | +16.5% |
Q1 2016 | $20,818,000 | – | 2,490,204 | – | 1.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|